¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"absorbed dose conversion factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
antiscorbutic factor
Ç×±«Ç÷º´ÀÎÀÚ
antisterility factor
Ç׺ÒÀÓÀÎÀÚ
atrial natriuretic factor
½É¹æ³ªÆ®·ýÀÌ´¢ÀÎÀÚ, ½É¹æ¼ÒµãÀÌ´¢ÀÎÀÚ
activation factor
Ȱ¼ºÀÎÀÚ
alveolar dilution factor
ÆóÆ÷Èñ¼®ÀÎÀÚ, ÇãÆÄ²Ê¸®Èñ¼®ÀÎÀÚ
amplification factor
ÁõÆøÀÎÀÚ
behavioral risk factor
ÇൿÀ§Çè¿äÀÎ
coagulation factor
ÀÀ°íÀÎÀÚ
coagulation factor inhibitor
ÀÀ°íÀÎÀÚ¾ïÁ¦Á¦
colony-stimulating factor
Áý¶ôÀÚ±ØÀÎÀÚ
common factor
°øÅëÀÎÀÚ
competence factor
1. ¸é¿ª°¡´ÉÀÎÀÚ 2. ¹ÝÀÀ°¡´ÉÀÎÀÚ
competence inducing factor
¸é¿ª°¡´ÉÀ¯¹ßÀÎÀÚ
complementary factor
º¸ÃæÀÎÀÚ
conglutinogen activating factor
±³Âø¿øÈ°¼ºÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
high dose rate intraluminal radiotherapy
°í¼±·®À²°ü³»¹æ»ç¼±Ä¡·á
high-dose tolerance
Ç׿ø°ú·®Çã¿ë
low dose rate irradiation
Àú¼±·®À²Á¶»ç
metered-dose inhaler
°è·®ÈíÀÔ±â
split dose irradiation
¼±·®ºÐ¸®Á¶»ç
low dose rate
Àú¼±·®·ü
low-dose tolerance
Ç׿ø¼Ò·®Çã¿ë
time dose relationship
½Ã°£¿ë·®°ü°è
activation factor
Ȱ¼ºÀÎÀÚ
alveolar dilution factor
ÆóÆ÷Èñ¼®ÀÎÀÚ, ÇãÆÄ²Ê¸®Èñ¼®ÀÎÀÚ
amplification factor
ÁõÆøÀÎÀÚ
antihemophlic factor
Ç×Ç÷¿ìº´ÀÎÀÚ
antineuritic factor
Ç׽Ű濰ÀÎÀÚ
antipellagra factor
Çׯç¶ó±×¶óÀÎÀÚ
antiphagocytic factor
Çׯ÷½ÄÀÛ¿ëÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
Luteinization -inhibiting factor
ȲüȾïÁ¦¿äÀÎ(üÜô÷ûùåäð¤é©ì×)
Macrophage colony-stimulating factor
´ë½Ä¼¼Æ÷Áý¶ôÇü¼ºÃËÁøÀÎÀÚ(ÓÞãÝá¬øàó¢Õªû¡à÷õµòäì×í)à÷õµòäì×?
NGF=>nerve growth factor
½Å°æ¼ºÀåÀÎÀÚ
PAF =platelet activating factor
Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ.
PAF= platelet activating factor
Ç÷¼ÒÆÇ Ȱ¼ºÀÎÀÚ.
Q factor
Å¥ ÀÎÀÚ
Q-factor
Å¥-ÀÎÀÚ (ì×í)
R factor
³»¼ºÀÎÀÚ.
R factor
³»¼ºÀÎÀÚ.
Rh factor
RhÀÎÀÚ.
Stuart-Prower factor
½ºÆ©¾îÆ®-ÇÁ¶ó¿ö ÀÎÀÚ
T cell activating factor
T¼¼Æ÷Ȱ¼ºÀÎÀÚ
T cell factor (TCF)
T¼¼Æ÷
T cell growth factor (TCGF, IL-2)
T¼¼Æ÷ Áõ½ÄÀÎÀÚ
T cell replacing factor
T¼¼Æ÷ ´ëüÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
dose costraint
¼±·®±¸¼ÓÄ¡
dose distribution
¼±·®ºÐÆ÷
dose equivalent
¼±·®´ç·®
dose limits (limitation)
¼±·®Çѵµ, ¼±·®Á¦ÇÑ
dose profile
¼±·®Ãø¸éµµ
dose rate
¼±·®À²
dose rate effect
¼±·®À²È¿°ú
dose rate meter
¼±·®À²°è, -ÃøÁ¤±â
dose rate variation
¼±·®·ü º¯È
dose response curve
¹æ»ç [¾à¸®,º´¸®,»ýÈ,ÇÙÀÇ]¿ë·®¹ÝÀÀ°î¼±(éÄåÖÚãëëÍØàÊ).
dose response curve
¹æ»ç ¾à¸®,º´¸®,»ýÈ,ÇÙÀǿ뷮´ëÀÀ°î¼±(éÄåÖÓßëëÍØàÊ).
dose response curve/relationship
¿ë·®-¹ÝÀÀ°î¼±/°ü°è.
dose response relationship
¹æ»ç ¾à¸®,»ý¸®,»ýÈ,ÇÙÀǿ뷮¹ÝÀÀ°ü°è (¡Î¼Ìõ).
dose units
¼ö·®´ÜÀ§.
dose, immunizing
¸é¿ª·®
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½